Psychometric Property of Japanese version of Patient Reported Outcome - Common Terminology Criteria for Adverse Event

Psychometric Property of Japanese version of Patient Reported Outcome - Common Terminology Criteria for Adverse Event - Psychometric Property of Japanese version of Patient Reported Outcome - Common Terminology Criteria for Adverse Event

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015169

Enrollment

180

Registered

2014-09-21

Start date

2015-03-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Currently receiving cancer therapy. 2. ECOG PS 0 to 4. 3. Sufficient language ability to understand and complete the questionnaire without assistance. 4. Provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1. Receiving only endocrine therapy. 2. Cognitive impairment. 3. Severe psychiatric disorder.

Design outcomes

Primary

Measure	Time frame
The psychometric properties, including criterion validity, construct validity, test-retest reliability, sensitivity, were assessed.	—

Countries

Japan

Contacts

Public ContactTempei Miyaji

The University of Tokyo Department of Clinical Trial Data Management, Graduate School of Medicine

tmiyaji@m.u-tokyo.ac.jp03-5800-9086

Outcome results